# Relmada Therapeutics (stock symbol: RLMD) Logo in transparent PNG and SVG formats

## Relmada Therapeutics Logo large

### Relmada Therapeutics Logo large Download PNG (47.47 KB)

![Relmada Therapeutics Logo large Download PNG (47.47 KB)](/img/orig/RLMD_BIG-17c90249.png)

### Relmada Therapeutics Logo large Download SVG (12.76 KB)

![Relmada Therapeutics Logo large Download SVG (12.76 KB)](/img/orig/RLMD_BIG-56096131.svg)

## Relmada Therapeutics Logo icon format

### Relmada Therapeutics Logo icon format Download PNG (111.39 KB)

![Relmada Therapeutics Logo icon format Download PNG (111.39 KB)](/img/orig/RLMD-271e1e86.png)

### Relmada Therapeutics Logo icon format Download SVG (6.68 KB)

![Relmada Therapeutics Logo icon format Download SVG (6.68 KB)](/img/orig/RLMD-99e49f70.svg)

## Relmada Therapeutics Logo large for dark backgrounds

### Relmada Therapeutics Logo large for dark backgrounds Download PNG (23.78 KB)

![Relmada Therapeutics Logo large for dark backgrounds Download PNG (23.78 KB)](/img/orig/RLMD_BIG.D-79050b96.png)

### Relmada Therapeutics Logo large for dark backgrounds Download SVG (10 KB)

![Relmada Therapeutics Logo large for dark backgrounds Download SVG (10 KB)](/img/orig/RLMD_BIG.D-8b53fed5.svg)

## Relmada Therapeutics Logo icon format for dark backgrounds

### Relmada Therapeutics Logo icon format for dark backgrounds Download PNG (46.16 KB)

![Relmada Therapeutics Logo icon format for dark backgrounds Download PNG (46.16 KB)](/img/orig/RLMD.D-4bcf00d9.png)

### Relmada Therapeutics Logo icon format for dark backgrounds Download SVG (4.62 KB)

![Relmada Therapeutics Logo icon format for dark backgrounds Download SVG (4.62 KB)](/img/orig/RLMD.D-88100519.svg)

## About Relmada Therapeutics

Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that is in Phase 3 clinical trials for the adjunctive or monotherapy treatment of major depressive disorder in adults. The company was founded in 2004 and is headquartered in Coral Gables, Florida.

1. Website domain: relmada.com
2. Employees: 10
3. Marketcap: $75.84 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
